August 15, 2021
1 min learn
The IOTA examine and a section 2 risuteganib trial led current cornea/exterior illness protection on Healio/OSN.
Try a number of the top-performing objects beneath.
IOTA examine: One donor cornea might assist deal with ‘lots of of sufferers’
As an alternative of utilizing one donor cornea for one affected person, endothelial cell remedy might enable tissue from one donor for use by as many as 100 sufferers. Read more.
VIDEO: Donnenfeld discusses risuteganib for dry eye illness
Eric D. Donnenfeld, MD, discusses the FDA section 2 trial of risuteganib in sufferers with dry eye illness. Watch here.
Prognosis key for correct therapy of infectious keratitis
Many instances of Acanthamoeba keratitis are misdiagnosed. Read more.
Compounded cyclosporine could also be possibility for dry eye therapy
Klarity-C was an appropriate various therapy for sufferers with dry eye illness, based on a examine printed in Medical Ophthalmology. Read more.
Synthetic endothelial layer reduces corneal edema, ache
A polymer movie implant hooked up to the posterior corneal floor can deal with corneal edema secondary to endothelial dysfunction and could also be an alternative choice to endothelial keratoplasty. Read more.